Company profile

Guangdong Pidi Pharmaceutical Co., LTD., founded in 1989, is located in Kaiping City, the famous hometown of overseas Chinese in the central and western parts of the Pearl River Delta, China. It is a pharmaceutical enterprise that produces and operates Chinese and western patent medicines, pharmaceutical and chemical raw materials. It is one of the first GMP certification enterprises in Guangdong Province, one of the 20 key pharmaceutical industry enterprises in Guangdong Province, the postdoctoral innovation practice base in Guangdong Province, the technology research and development center in Guangdong Province, the famous trademark of Guangdong Province, and national high-tech enterprise.

The company has the garden - style layout, beautiful environment. The production workshop is divided into headquarters workshop and a branch factory. Headquarters workshops have oral solid, large volume injection, spray, penicillin and other dedicated workshops, and a number of GMP certified automatic production lines. The factory produces 2 billion tablets, 500 million capsules, 400 million bags of granules and 30 million bottles of large-volume injection annually. One branch is dedicated to the production of omeprazole pellet intermediates and auxiliary materials used to replace imports: water dispersions of methacrylate - ethyl acrylate copolymer. At present, the company has anti-bacterial, anti-virus, cardiovascular and cerebrovascular, analgesic and anti-inflammatory, digestive system, respiratory system and other therapeutic drugs series, a total of more than 140 varieties, including more than 50 varieties in production. At the beginning of 2020, the company added a mask workshop for the production of disposable protective masks, disposable medical masks and N95 masks, with an annual output of 100 million. The company has more than 600 employees, including more than 250 technical personnel above junior college. After more than 30 years of unremitting efforts by all staff, the company has developed into a modern pharmaceutical enterprise with total assets of more than 700 million yuan. In 2021, the sales revenue is nearly 500 million yuan, and the total tax payment is over 65 million yuan. For this reason, the company has been awarded the special outstanding enterprise by the government financial and tax departments for many times .

The company has been engaged in scientific and efficient operation management in generic drug research and development, process prescription design, drug testing and quality control, automatic clean production. In terms of investment in new dosage forms and new technologies, the company mainly focuses on projects with few domestic and high technical difficulties, and invests no less than 5% of revenue in the research and development of new products every year.

In recent years, we have successively developed a series of 26 new drugs for digestive system, cardio-cerebrovascular system, endocrine system, anti-bacterial, anti-virus, analgesic and anti-inflammatory, and nutrient solution. In addition, the company also mastered the advanced technology of pharmaceutical sustained-release pellet production technology, the production of Omeprazole capsules (trade name: Bisike) is a well-known brand in China, is also one of the few domestic enterprises to master the sustained-release preparation production technology. Each index is among the best in the chemical pharmaceutical preparation enterprises in the region.

The company has been adhering to the strategy of sustainable development based on science and technology. In 2008, the company formally established the pharmaceutical research Institute, focusing on the transformation research of pharmaceutical achievements and the improvement of product quality, in order to become a high-end pharmaceutical research institute with professional talents and advanced equipment. In 2011, the company cooperated with the School of Pharmacy of Sun Yat-sen University to build a joint laboratory of Sun Yat-sen University- Pidi Pharmaceutical. With the help of the scientific research platform of Sun Yat-sen University, the company introduces high-end R&D talents and realizes the sharing of scientific research resources, aiming to promote the development of controlled release preparations and leading new drugs at home and abroad. In 2016, the company invested a huge sum of money to establish Guangdong Pisri Pharmaceutical Research Co., LTD in Panyu Tsinghua Science and Technology Park, Guangzhou, in accordance with the research and development strategy and actively adapt to the requirements of bioequivalence evaluation of solid preparations of chemical generics initiated by the state, mainly targeting at the research and development of chemical generics (solid preparations). The company will make full use of this platform to gather outstanding talents who are interested in the development of generic drugs, and carry out scientific and fruitful work in pharmaceutical research, quality analysis, prescription screening, product pilot and pilot scale.

In addition, the company also carries on the product cooperation and exchange with the national famous research and development institutions every year.

With the increasing popularity of "Pidi Medicine", the company's product sales network has been throughout the country. In 2021, the company will have more than 4,000 basic customers for drug sales. The company's marketing network from the national and provincial pharmaceutical commercial companies have been extended to retail terminals, each salesman are dedicated to customer management and maintenance.

Pidi pharmaceutical advocates the business philosophy of "create smile with heart", and has formed a dedicated and inclusive corporate culture over the years. Based on excellent team, efficient management, dedicated service and excellent performance, the company is constantly forging ahead. With high quality product, Pidi pharmaceutical pursues to create effective value for customers, and sincerely win-win for partners. In the end, we will participate in and promote the development of Chinese medicine and bring a healthy smile to human beings.

Pidi pharmaceutical sincerely look forward to cooperating with you and win-win together.

 Copyright:Guangdong Pidi Pharmaceutical Co., LTD.